A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications

Table 4 Summary of the Diabetes Treatment Satisfaction Questionaries (DTSQ) measures

DTSQ items	No retinopathy	Retinopathy	p-value
Hyperglycemias frequency perception	2.46 (2.23)	3.58 (2.19)	<0.001
	2 [0,4]	0 [2,6]	<0.001
Hypoglycemias frequency perception	0.99 (1.63)	1.64 (2.12)	0.008
	0 [0,2]	0 [0,3]	0.008
Current treatment	5.00 (1.48)	4.8 (1.53)	0.445
	5 [5,6]	5[4,6]	0.445
Convenience	4.99 (1.63)	4.41 (1.82)	<0.001
	6 [5,6]	5 [4,6]	<0.001
Flexibility	3.34 (2.49)	2.91 (2.36)	0.057
	4 [0,6]	3 [0,5]	0.057
Understanding	4.37 (1.89)	4.45 (1.85)	0.808
	5 [3,6]	5 [3,6]	0.808
Recommend to others	3.19 (2.23)	3.00 (2.27)	0.362
	3 [1,5]	3 [0.75,5]	0.362
Continue with	5.81 (0.85)	5.76 (1.00)	0.642
	6 [6,6]	6 [6,6]	0.642
Final score	26.73 (5.61)	25.43 (6.70)	0.236
	27 [23,30]	26 [21.75,31]	0.236

Mean (standard deviation) in first line, and median [P25,P75] in second line. The p-values correspond to the unadjusted univariate analysis that compares the difference for each variable between patients with and without retinopathy.

ISSN: 1477-7525